Nanoviricides Inc (NNVC)
1.85
-0.41
(-18.14%)
USD |
NYAM |
May 15, 16:00
1.85
0.00 (0.00%)
After-Hours: 16:14
Nanoviricides Free Cash Flow: -6.203M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.203M |
| September 30, 2023 | -5.924M |
| June 30, 2023 | -5.822M |
| March 31, 2023 | -5.794M |
| December 31, 2022 | -5.691M |
| September 30, 2022 | -6.544M |
| June 30, 2022 | -6.216M |
| March 31, 2022 | -7.055M |
| December 31, 2021 | -6.906M |
| September 30, 2021 | -6.930M |
| June 30, 2021 | -8.453M |
| March 31, 2021 | -7.853M |
| December 31, 2020 | -8.705M |
| September 30, 2020 | -7.507M |
| June 30, 2020 | -6.674M |
| March 31, 2020 | -6.643M |
| December 31, 2019 | -6.263M |
| September 30, 2019 | -7.315M |
| June 30, 2019 | -6.877M |
| March 31, 2019 | -8.731M |
| December 31, 2018 | -8.143M |
| September 30, 2018 | -7.430M |
| June 30, 2018 | -8.018M |
| March 31, 2018 | -5.537M |
| December 31, 2017 | -6.255M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.401M |
| June 30, 2017 | -8.063M |
| March 31, 2017 | -8.441M |
| December 31, 2016 | -8.936M |
| September 30, 2016 | -7.567M |
| June 30, 2016 | -7.306M |
| March 31, 2016 | -8.323M |
| December 31, 2015 | -8.021M |
| September 30, 2015 | -12.70M |
| June 30, 2015 | -12.97M |
| March 31, 2015 | -13.09M |
| December 31, 2014 | -13.87M |
| September 30, 2014 | -10.22M |
| June 30, 2014 | -11.56M |
| March 31, 2014 | -10.37M |
| December 31, 2013 | -8.956M |
| September 30, 2013 | -8.051M |
| June 30, 2013 | -5.798M |
| March 31, 2013 | -5.322M |
| December 31, 2012 | -5.044M |
| September 30, 2012 | -4.916M |
| June 30, 2012 | -4.276M |
| March 31, 2012 | -4.244M |
| December 31, 2011 | -4.079M |
| September 30, 2011 | -3.834M |
Free Cash Flow Range, Past 5 Years
-8.705M
Minimum
Dec 2020
-5.691M
Maximum
Dec 2022
-6.809M
Average
-6.674M
Median
Jun 2020
Free Cash Flow Benchmarks
| EyePoint Pharmaceuticals Inc | -16.65M |
| Enanta Pharmaceuticals Inc | -113.29M |
| GlycoMimetics Inc | -33.81M |
| FibroGen Inc | -274.68M |
| Corvus Pharmaceuticals Inc | -20.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.719M |
| Cash from Investing (Quarterly) | -0.0055M |
| Free Cash Flow Per Share (Quarterly) | -0.1468 |
| Free Cash Flow Yield | -28.68% |